MEDIA | Biotech Daily

Biotech Daily has highlighted Avecho’s share price performance following the announcement of its eclusive agreement with international pharma company, Sandoz AG.

“Avecho was up 120 percent in the weeks ahead of today’s announced Sandoz deal to $22 million, Inhalerx was up 25 percent from $4 million to $5 million, Little Green was up 24.2 percent to $41 million and Vitura rose 11.1 percent to $50 million.”

Read the article.